News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Covidien Ltd to Report Third-Quarter Results on August 5, 2008
July 9, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
HAMILTON, Bermuda--(BUSINESS WIRE)--Covidien Ltd. (NYSE: COV, BSX: COV) will report third-quarter results before trading begins on August 5, 2008. The Company will hold a conference call for investors at 8:30 a.m. ET.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Layoff Tracker
GSK restructure will hit home, impacting ‘limited’ UK roles
October 28, 2026
·
110 min read
·
BioSpace Editorial Staff
Earnings
GSK vaccine sales miss expectations amid falling demand from adults
October 28, 2026
·
2 min read
·
Nick Paul Taylor
Immuno-oncology
Astellas bets up to $1.34B for option to advance Audax immuno-oncology asset
October 28, 2026
·
2 min read
·
Tristan Manalac
Earnings
Biogen notches 3rd straight quarter of growth thanks to newer products, Apellis
October 28, 2026
·
1 min read
·
Annalee Armstrong